Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
Not Confirmed
Not Confirmed
29 September-01 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Industry Trade Show
Not Confirmed
29 September-01 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
15 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/15/3149935/0/en/Avalyn-to-Highlight-AURA-IPF-Phase-2-Clinical-Trial-Design-for-AP02-Inhaled-Nintedanib-at-the-European-Respiratory-Society-International-Congress-2025.html
25 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/25/3138403/0/en/Avalyn-to-Participate-in-Multiple-Upcoming-Investor-Conferences-in-September.html
22 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/22/3119277/0/en/Avalyn-Completes-Oversubscribed-100-Million-Series-D-Financing-to-Further-Advance-Clinical-Development-of-Novel-Inhaled-Therapies-for-Pulmonary-Fibrosis.html
22 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com//www.fiercepharma.com/pharma/avalyn-raises-100m-series-d-advance-inhaled-versions-approved-lung-disease-meds
22 Jul 2025
// BIOSPACE
https://www.biospace.com/business/avalyn-pharma-adds-100m-series-d-for-inhaled-pulmonary-fibrosis-drugs
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088563/0/en/Avalyn-Announces-Upcoming-Presentation-on-its-Lead-Program-AP01-Inhaled-Pirfenidone-for-the-Treatment-of-Pulmonary-Fibrosis-at-the-European-Congress-of-Rheumatology-2025.html
ABOUT THIS PAGE